Melinta Therapeutics Inc (MLNTQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | ||
| Net Income | -19,670 | -18,610 |
| Depreciation Amortization | 40 | 20 |
| Other Working Capital | 410 | -770 |
| Other Operating Activity | 1,670 | 2,050 |
| Operating Cash Flow | $-17,550 | $-17,310 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -160 | -20 |
| Investing Cash Flow | $-160 | $-20 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | 20,490 | 25,240 |
| Financing Cash Flow | $20,490 | $25,240 |
| Beginning Cash Position | 17,260 | 9,350 |
| End Cash Position | 20,040 | 17,260 |
| Net Cash Flow | $2,780 | $7,910 |
| Free Cash Flow | ||
| Operating Cash Flow | -17,550 | -17,310 |
| Free Cash Flow | -17,550 | -17,310 |